Physician profile
Brian Choi
NPI 1386602720
$34,693.79
in general payments reported to CMS, 2019-2025
100 companies · $6,502 in 2025
The $6,502 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,820 · 2020: $3,742 · 2021: $4,343 · 2022: $5,081 · 2023: $4,620 · 2024: $6,585 · 2025: $6,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,486.68 |
| Education | $220.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,881.59 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Merck Sharp & Dohme LLC | $2,565.73 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Novartis Pharmaceuticals Corporation | $2,560.61 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,889.48 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Pfizer INC. | $1,596.66 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,498.08 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Celgene Corporation | $1,085.35 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Genzyme Corporation | $1,078.77 | 2019-2025 | |
| Astellas Pharma US INC | $895.76 | 2019-2025 | Xtandi, Xospata, Vyloy |
| Eisai INC. | $827.34 | 2019-2025 | |
| Glaxosmithkline, LLC. | $766.41 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Incyte Corporation | $765.65 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Amgen INC. | $742.01 | 2019-2025 | Lumakras, Blincyto, Kyprolis |
| Genentech USA, INC. | $719.72 | 2019-2025 | Tecentriq, Polivy, Lunsumio |
| Lilly USA, LLC | $705.60 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $695.79 | 2019-2025 | Venclexta |
| Puma Biotechnology, INC. | $681.47 | 2019-2025 | Nerlynx |
| Beigene USA, INC. | $588.92 | 2020-2025 | Brukinsa, Tevimbra |
| Gilead Sciences, INC. | $567.48 | 2021-2025 | Trodelvy |
| Array Biopharma INC | $544.44 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Seagen INC. | $541.06 | 2019-2023 | Adcetris, Padcev |
| Karyopharm Therapeutics INC. | $537.76 | 2020-2025 | Xpovio |
| Aveo Pharmaceuticals, INC. | $528.98 | 2021-2025 | Fotivda |
| Alexion Pharmaceuticals, INC. | $513.62 | 2021-2025 | Ultomiris |
| Sobi, INC | $467.51 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $465.67 | 2019-2025 | Alunbrig, Iclusig, Fruzaqla |
| Daiichi Sankyo INC. | $459.90 | 2019-2025 | Enhertu, Datroway |
| Regeneron Healthcare Solutions, INC. | $401.75 | 2020-2025 | Libtayo |
| Rigel Pharmaceuticals, INC. | $394.99 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Bayer Healthcare Pharmaceuticals INC. | $355.67 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $318.79 | 2019-2023 | Imbruvica, Epkinly |
| Exelixis INC. | $301.04 | 2019-2025 | Cabometyx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.82 | 2019-2025 | Gilotrif |
| Ipsen Biopharmaceuticals, INC | $258.86 | 2019-2025 | Onivyde, Somatuline Depot |
| Pharmaessentia USA Corporation | $226.39 | 2022-2025 | Besremi |
| Beone Medicines USA, INC. | $210.57 | 2025 | Brukinsa, Tevimbra |
| Blueprint Medicines Corporation | $192.22 | 2020-2025 | Ayvakit |
| Taiho Oncology, INC. | $183.95 | 2020-2025 | |
| Dova Pharmaceuticals | $183.70 | 2019-2021 | |
| Deciphera Pharmaceuticals INC. | $172.85 | 2021-2025 | Qinlock, Tgct, Romvimza |
| Kite Pharma, INC. | $161.08 | 2021-2025 | Yescarta |
| Foundation Medicine, INC. | $158.10 | 2019-2023 | |
| Emd Serono, INC. | $155.95 | 2019-2025 | |
| Adc Therapeutics America, INC. | $155.48 | 2022-2025 | |
| Livanova USA, INC. | $147.11 | 2021 | |
| Coherus Oncology, INC. | $146.26 | 2020-2025 | Loqtorzi, Udenyca |
| Amag Pharmaceuticals, INC. | $143.85 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $126.71 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $125.70 | 2019-2025 | Provenge |
| Acrotech Biopharma INC. | $111.75 | 2021-2025 | Beleodaq |
| Stemline Therapeutics INC. | $106.97 | 2023-2025 | Orserdu |
| Adaptive Biotechnologies Corporation | $104.67 | 2022-2024 | Clonoseq |
| Eusa Pharma (US) LLC | $104.42 | 2019-2021 | |
| Csl Behring | $101.62 | 2020-2023 | Afstyla, Idelvion |
| Morphosys, US INC. | $88.47 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $86.05 | 2020-2022 | |
| Fennec Pharmaceuticals, INC. | $84.15 | 2023-2025 | Fyarro, Pedmark |
| Tempus Ai, INC | $79.30 | 2024-2025 | Xt Cdx |
| Sanofi-Aventis U.S. LLC | $78.11 | 2019-2020 | |
| Caris Mpi, INC. | $77.62 | 2025 | Mi Cancer Seek |
| Immunocore Limited | $75.51 | 2023 | Kimmtrak |
| Legend Biotech USA INC. | $69.86 | 2024-2025 | Carvykti |
| Sumitomo Pharma America, INC. | $67.64 | 2024-2025 | Orgovyx |
| Myovant Sciences INC. | $60.93 | 2021 | |
| Tersera Therapeutics LLC | $59.18 | 2019-2025 | Zoladex |
| Pharmacosmos Therapeutics INC. | $57.42 | 2024-2025 | Monoferric, Cosela |
| Springworks Therapeutics, INC. | $56.80 | 2024-2025 | Ogsiveo |
| Progenics Pharmaceuticals, INC. | $55.09 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $54.64 | 2021-2022 | |
| Aurobindo Pharma USA, INC. | $54.59 | 2019-2020 | |
| Genmab U.S., INC. | $53.46 | 2024 | Epkinly |
| Mirati Therapeutics, INC. | $53.34 | 2023 | Krazati |
| Octapharma USA, INC. | $52.78 | 2021-2022 | |
| Kyowa Kirin, INC. | $48.21 | 2019-2025 | Poteligeo |
| Syndax Pharmaceuticals, INC. | $47.20 | 2025 | |
| Janssen Pharmaceuticals, INC | $47.18 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $43.70 | 2020-2022 | |
| Servier Pharmaceuticals LLC | $43.35 | 2021-2025 | |
| Verastem, INC. | $42.88 | 2019-2020 | |
| Clovis Oncology, INC. | $42.74 | 2020 | |
| Epizyme, INC. | $42.29 | 2021 | |
| Novo Nordisk INC | $41.76 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $40.74 | 2019 | |
| Novocure INC. | $40.30 | 2023-2025 | Optune Gio, Optune |
| Agios Pharmaceuticals, INC. | $39.21 | 2021-2023 | Pyrukynd |
| Chiesi USA, INC. | $38.27 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $33.58 | 2024 | Sancuso |
| Ge Healthcare | $33.28 | 2021-2025 | |
| Tesaro, INC. | $33.13 | 2019 | |
| Geron Corporation | $25.34 | 2025 | Rytelo |
| Teva Pharmaceuticals USA, INC. | $25.05 | 2019 | |
| Recordati_rare_diseases_inc. | $23.88 | 2024 | Sylvant |
| Alnylam Pharmaceuticals INC. | $22.95 | 2022 | |
| Iovance Biotherapeutics, INC. | $22.77 | 2025 | Amtagvi |
| Immunogen, INC. | $20.76 | 2023 | Elahere |
| Spectrum Pharmaceuticals INC. | $20.52 | 2024 | Rolvedon |
| Apo-Pharma USA, INC. | $18.01 | 2019 | |
| Accord Healthcare, INC. | $17.56 | 2024 | |
| Sirtex Medical INC | $17.09 | 2020 | |
| Mylan Institutional INC. | $16.60 | 2019 |
Drugs and devices associated with these payments
Keytruda $1,312Lenvima $685Darzalex $608Tecvayli $574Brukinsa $473Imbruvica $430Rybrevant $418Enhertu $414Calquence $400Kisqali $374Adcetris $349Ultomiris $334Fotivda $333Doptelet $328Pomalyst $323Talvey $318Xpovio $311Jakafi $305Braftovi $298Elrexfio $280Reblozyl $269Pluvicto $262Tavalisse $251Rezlidhia $251Erleada $249Mektovi $239Libtayo $239Trodelvy $237Scemblix $236Opdivo $236Sarclisa $234Lynparza $233Tukysa $232Epkinly $224Jaypirca $209Elahere $209Nerlynx $206Padcev $203Imfinzi $203Inlyta $203Cabometyx $196Verzenio $194Besremi $194Nubeqa $191Fabhalta $188Keytruda Qlex $187Alunbrig $179Ojjaara $178Lorbrena $157Tevimbra $156Inqovi $155Lonsurf $155Tecentriq $153Xtandi $149Bosulif $143Onivyde $140Tivdak $135Orgovyx $133Retevmo $128Lutathera $124Welireg $123Qinlock $122Iclusig $118Polivy $116Somatuline Depot $115Piqray $109Ibrance $108Orserdu $107Carvykti $106Zynlonta $105Balversa $104Akeega $104Jemperli $93.97Loqtorzi $92.55Opdualag $85.33Clonoseq $81.47Mekinist $79.67Xospata $78.63Mi Cancer Seek $77.62Kimmtrak $75.51Ayvakit $71.80Fyarro $68.42Yescarta $66.08Synagis $63.83Beleodaq $58.57Ogsiveo $56.80Pylarify $55.09Krazati $53.34Provenge $53.03Kyprolis $49.91Gilotrif $47.32Vyloy $47.28Udenyca $47.14Gavreto $44.32Elitek $44.25Fruzaqla $43.01Zepzelca $42.95Tagrisso $42.51Xalkori $42.03Monoferric $40.86
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.